Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling

Area of Science:

• Cardiovascular Physiology
• Molecular Cardiology
• Pharmacology

Background:

• Heart failure is a major global health burden with limited effective therapies.
• Current treatments often target cAMP signaling, which can be problematic in heart failure.
• Nitroxyl (HNO), a nitric oxide (NO) metabolite, shows potential for improving cardiac function.

Purpose of the Study:

• To elucidate the molecular mechanism by which nitroxyl (HNO) enhances cardiac myocyte contraction.
• To investigate the direct targets of HNO within the cardiac sarcoplasmic reticulum.
• To determine if HNO's effects are mediated by established signaling pathways like cAMP or cGMP.

Main Methods:

• Studied isolated sarcoplasmic reticulum Ca(2+) pumps and ryanodine receptors.
• Assessed the effects of HNO on Ca(2+) uptake and release kinetics.
• Evaluated the role of redox sensitivity and signaling pathways (PKA, PKG) in HNO's action.
• Utilized isolated cardiac myocytes and in vivo models of normal and failing hearts.

Main Results:

• HNO directly interacts with the sarcoplasmic reticulum Ca(2+) pump and ryanodine receptor 2.
• HNO enhances Ca(2+) uptake and release from the sarcoplasmic reticulum, improving contraction without increasing diastolic calcium.
• These effects are redox-sensitive, reversible, and independent of cAMP/PKA and cGMP/PKG signaling.
• HNO's action is attributed to HNO/thiolate interactions with intracellular Ca(2+) cycling proteins.

Conclusions:

• Nitroxyl (HNO) improves cardiac contractility through direct modulation of key Ca(2+) handling proteins.
• The mechanism involves enhanced Ca(2+) cycling, distinct from NO or cAMP-mediated pathways.
• HNO donors represent a promising therapeutic avenue for heart failure treatment.